Build 'VetOncoAI'—a SaaS platform that uses AI to optimize oral chemotherapy dosing, monitor treatment efficacy, and predict remission likelihood for canine lymphoma. The platform would: 1) Deploy computer vision to analyze pet wearables (e.g., FitBark) and home videos for symptoms (e.g., 'Lethargy detected: 90% confidence'); 2) Provide a 'Dosing Optimization Dashboard' showing real-time adjustments (e.g., 'Reduce Laverdia® dose by 15%'); 3) Integrate with veterinary EHR APIs (e.g., IDEXX) to auto-generate FDA-compliant reports; 4) Offer a 'Cost Predictor' to estimate treatment expenses and connect owners to pet insurance/funding programs.

Market Catalyst & News Trigger

"Anivive Lifesciences Announces FDA Approval of Laverdia®, the First Oral Treatment of Its Kind for Canine Lymphoma"

The Workflow Friction

Veterinarians, pet owners, and animal pharmaceutical companies Canine lymphoma treatment has historically relied on injectable chemotherapies, which are expensive ($5K–$10K per cycle), require frequent vet visits, and cause significant stress for pets and owners. Oral treatments are rare due to bioavailability challenges, and no AI-driven platforms exist to optimize dosing or predict treatment outcomes for animals. The global veterinary oncology market is $1.2B+, with 50% of pet owners opting for euthanasia due to cost and treatment complexity. The operational cost of manual dosing adjustments and follow-ups averages $300 per visit.

Problem Summary

Real-world problem signal validation.

One-Shot MVP Builder Blueprint (48 Hours)

Build a mobile app (React Native) that allows pet owners to upload videos, wearable data, and lab results. Use a lightweight LLM to generate dosing recommendations and symptom alerts. Include a 'Vet Portal' for real-time monitoring and a 'Owner Portal' for treatment updates. Pilot with 5 veterinary oncology clinics in California.

Recommended Developer Tech Stack

• React
• FastAPI
• PostgreSQL
• AWS Rekognition
• Stripe API